Evolving trends and treatment advances in pediatric poisoning

JAMA

Volumn 282, Issue 12, 1999, Pages 1113-1115

  Liebelt, Erica L ^a   DeAngelis, Catherine D ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST BENEFIT ANALYSIS; HUMAN; INTOXICATION; POISON CENTER; PRIORITY JOURNAL; REVIEW; RISK FACTOR; UNITED STATES;

EID: 0033615273     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.282.12.1113     Document Type: Review

References (20)

1. Litovitz TL, Klein-Schwartz W, Dyer KS, Shannon M, Lee S, Powers M. 1997 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 1998;16:443-497.
2. Litovitz TL, Manoguerra A. Comparison of pediatric poisoning hazards: an analysis of 3.8 million exposure incidents. Pediatrics, 1992;89:999-1006.
3. Lovejoy FH, Robertson WO, Woolf AD. Poison centers, poison prevention, and the pediatrician. Pediatrics. 1994;94:220-224.
4. Miller TR, Lestina DC. Costs of poisoning in the United States and savings from poison control centers: a benefit-cost analysis. Ann Emerg Med. 1997; 29:239-245.
5. Rodgers GB. The safety effects of child-resistant packaging for oral prescription drugs: two decades of experience. JAMA. 1996;275:1661-1665.
6. American Academy of Clinical Toxicology, European Association of Poison Centres and Clinical Toxicologists. Position statement: ipecac syrup. Clin Toxicol. 1997;35:699-709.
7. Bond GR, Requa RK, Krenzelok EP, et al. Influence of time until emesis on the efficacy of decontamination using acetaminophen as a marker in a pediatric population. Ann Emerg Med. 1993;22:1403-1407.
8. Bond GR. Home use of syrup of ipecac is associated with a reduction in pediatric emergency department visits. Ann Emerg Med. 1995;25:338-343.
9. Kornberg AE, Dolgin J. Pediatric ingestions: charcoal alone versus ipecac and charcoal. Ann Emerg Med. 1991;20:648-651.
10. American Academy of Clinical Toxicology, European Association of Poison Centres and Clinical Toxicologists. Position statement: single dose charcoal. Clin Toxicol. 1997;35:721-741.
11. Pond SM, Lewis-Driver DJ, Williams GM, Green AC, Stevenson NW. Gastric emptying in acute overdose: a prospective randomised controlled trial. Med J Aust. 1995;163:345-349.
12. Lamminpää A, Vilska J, Hoppu K. Medical charcoal for a child's poisoning at home: availability and success of administration in Finland. Hum Exp Toxicol. 1993;12:29-32.
13. American Academy of Clinical Toxicology; European Association of Poison Centres and Clinical Toxicologists. Position statement: gastric lavage. Clin Toxicol. 1997;35:711-719.
14. Tenenbein M. Whole bowel irrigation in iron poisoning. J Pediatr. 1987;111:142-145.
15. Woolf AD, Wenger T, Smith TW, Lovejoy FH. The use of digoxin-specific Fab fragments for severe digitalis intoxication in children. N Engl J Med 1992;326: 1739-1744.
16. Shannon M, Albers G, Burkhart K, et al. Safety and efficacy of flumazenil in the reversal of benzodiazepine-induced conscious sedation. J Pediatr. 1997; 131:582-586.
17. Boyle PJ, Justice K, Krentz AJ, Nagy RJ, Schade DS. Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses. J Clin Endocrinol Metab. 1993;76:752-756.
18. Brent J, McMartin K, Phillips S, et al. Fomepizole for treatment of ethylene glycol poisoning. N Engl J Med. 1999;340:832-838.
19. Scalzo AJ, Weber TR, Jaeger RW, et al. Extracorporeal membrane oxygenation for hydrocarbon aspiration. AJDC. 1990;144:867-871.
20. Liebelt EL. Targeted management strategies for cardiovascular toxicity from tricyclic antidepressant overdose: the pivotal role for alkalinization and sodium loading. Pediatr Emerg Care. 1998;14:293-298.